Doctor of Osteopathy Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Angela Walker

Orthopaedic Surgery Kansas City, MO Doctor of Osteopathy

NPI 1255771630 CMS profile 192613

2790 Clay Edwards Dr Ste 650, Kansas City, MO 64116

Open in the dashboard

General payments

$23,958

261 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Angela Walker of Kansas City, MO is reported in the CMS Open Payments database as having received $23,958 across 261 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 82nd percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $5,400 78
2024 General $3,580 47
2023 General $2,954 39
2022 General $4,152 40
2021 General $4,714 17
2020 General $1,392 8
2019 General $1,766 32

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Angela Walker
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Angela Walker were reported at $5,400. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Angela Walker Orthopaedic Surgery median Middle half National median
2019 $1,766 $644 $140–$2,844 $163
2020 $1,392 $312 $75–$1,860 $114
2021 $4,714 $520 $117–$2,495 $132
2022 $4,152 $598 $128–$2,731 $149
2023 $2,954 $461 $128–$2,264 $160
2024 $3,580 $497 $134–$2,475 $164
2025 $5,400 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $13,368 185 payments
  2. Arthrex, Inc. $6,594 42 payments
  3. Titan Surgical Group, LLC $3,095 12 payments
  4. Zimmer Biomet Holdings, Inc. $434 6 payments
  5. Bioventus LLC $101 5 payments
  6. Organogenesis Inc. $85 3 payments
  7. Wright Medical Technology, Inc. $84 1 payment
  8. Smith+Nephew, Inc. $73 1 payment
  9. Avanos Medical $28 1 payment
  10. PolyNovo North America LLC $26 1 payment
  11. Other $69 4 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Food and Beverage $8,492 227 payments
  2. Travel and Lodging $7,074 24 payments
  3. Education $6,117 8 payments
  4. Consulting Fee $2,275 2 payments
Products named General payments · program years 2019–2025
  1. INBONE $3,536 31 payments
  2. INFINITY $3,248 33 payments
  3. ORTHOLOC 3DI $2,127 4 payments
  4. INCOMPASS TOTAL ANKLE SYSTEM $2,100 1 payment
  5. PROPHECY $1,769 21 payments
  6. INVISION $897 7 payments
  7. INFINITY ADAPTIS $741 14 payments
  8. PROSTEP $739 4 payments
  9. CITREFIX $425 19 payments
  10. VARIAX $419 5 payments
  11. Other $4,254 108 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 7 drugs

Part D claims

483

Median for Orthopedic Surgery: 203

Drug cost

$3,063

Median for Orthopedic Surgery: $1,433

Branded share of claims

54.2%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 205 $1,614
Oxycodone Hcl Generic 131 $676
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 32 $237
Acetaminophen-Codeine Acetaminophen With Codeine Brand 25 $187
Tramadol Hcl Generic 52 $161
Cephalexin Generic 12 $108
Meloxicam Generic 26 $81

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 91 billing codes

Paid by Medicare

$78,099

Of which drugs: $142

Medicare patients

362

Average age 73

Services billed

1,071

248 women, 114 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Depression 31%
Ischemic heart disease 30%
Diabetes 28%
Chronic kidney disease 22%
Atrial fibrillation 17%
Cancer 17%
Drugs given in the clinic that this provider billed Medicare Part B for
Drug given in the clinic Where Patients Services Paid by Medicare
Injection, triamcinolone acetonide, not otherwise specified, 10 mg J3301 Office 29 194 $142

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

261 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Missouri

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record